Why partner with us?
UT Health Physicians have over 100 specialties and subspecialties with 1.6 million patient visits per year at 16 clinics.
The Mays Cancer Center is home to the world-renowned Institute for Drug Development (IDD) where many of the most commonly used FDA-approved anticancer drugs were developed. At any given time, the IDD is testing as many as 60 new drugs and drug combinations and has over 180 clinical trials open for patient enrollment.
UT Dentistry offers 9 specialty clinics staffed by more than 100 faculty experts.
For over a decade, the Association for the Accreditation of Human Research Protection Programs (AAHRPP) has recognized the ethical and efficient operations of our clinical research program.
As a Clinical and Translational Science Award (CTSA) hub, we emphasize the importance of accelerating the research process to translate scientific discovery and offer a master IRB reliance agreement through a SMART IRB platform expediting the regulatory approval process for multisite studies.
San Antonio is the largest minority-majority city in the United States and is home to 7 military installations comprising a large active-duty and retired military population with unique needs.
Through multi-modal strategies, we aim to bring more awareness to our communities about their role in clinical trials.
Contact Us
Mays Cancer Center Clinical Trials Office
Cindy McKeown, RN, BSN, MPA
$6,638,575
industry clinical trial revenue in 2020
Over 170
actively recruiting cancer trials
20
institutes and centers with diverse research specialties
Innovation Highlight
COVID-19 Vaccine Study Site
Dr. Barbara Taylor is leading a COVID-19 research team conducting a clinical trial evaluating an investigational vaccine to see if it helps prevent COVID-19.
Advancing Commercialization
Collaborating to produce low-cost ventilators
UT Health San Antonio researchers are collaborating with a team from The University of Texas at Austin to build a new type of ventilator made of inexpensive, widely available materials to help fill the demand created by the spread of COVID-19 for these critical devices that help patients breathe.
Robert J. Chilton, D.O., associate professor of medicine and director of the Cardiac Catheterization Laboratory at the Audie L. Murphy Memorial Veterans' Hospital“UT Health San Antonio cardiologists have led pinnacle studies that changed the standard of care for patients. Findings from the multi-site study, COURAGE, remain the gold standard treatment used for patients, worldwide. Our team is proud to lead trials at the South Texas Veteran’s Audie Murphy Hospital, a proven national leader in patient recruitment and retention.”
Spotlight
Pilot study aims to improve diet patterns in Asian Americans with diabetes
Dr. Jisook Ko, assistant professor in the School of Nursing, who is a scientist of the Asian Resource Center for Minority Aging Research supported by the National Institute on Aging was selected to receive a pilot grant of $34,920.
Study will compare 2 treatment strategies for severe brain injury; public comment requested
A study of emergency care involving victims of severe brain trauma is to be performed in the San Antonio area. The study will include adults and children older than 14 years with severe brain injury requiring admission to the ICU with brain monitoring. Hospitals across the country are conducting the study, which is funded by the U.S. National Institutes of Health.
New Drug Approved for Treating Rare Blood Cancer
Dr. Ruben Mesa was part of the international research team that led the development and approval of fedratinib, becoming the 2nd drug that can be used to treat myelofibrosis, after huge success in Phase 3 trial, JAKARTA.